NCT04162873 2025-02-12
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
University of Utah
Phase 2 Terminated
Clinical Trials
10 trialsNCT03254927 2023-04-03
A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma
Celldex Therapeutics
Phase 2 Terminated
NCT02917629 2023-03-08
ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment
National Cancer Institute (NCI)
Phase 2 Terminated
NCT03258008 2022-12-16
Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT03713021 2022-07-12
TraceIT Tissue Marker to Mark the Primary Resection Bed Margins of Oropharyngeal Cancers
Washington University School of Medicine
Phase NA Terminated
NCT04015336 2022-02-24
E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT01687413 2020-11-25
ADEPT
Washington University School of Medicine
Phase 3 Terminated
NCT01883908 2019-11-07
GCC1229
University of Maryland, Baltimore
Phase NA Terminated
NCT01525927 2017-12-19
Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity
Northwell Health
Phase 2 Terminated
NCT00537199 2016-05-13
OraTest in Combination With Visual Examination and Visual Examination Alone
M.D. Anderson Cancer Center
Phase 3 Terminated